PIONEER-HF demonstrated that the reduction of NT-proBNP with in-hospital initiation of sacubitril/valsartan was significantly greater in comparison to enalapril and this beneficial effect was prominent from week 1 [54]. This evidence concerns the gene NPPB and hydrops fetalis.